Association of 6% hydroxyethyl starch 130/0.4 with acute kidney injury in surgical patients in the postoperative period: a multicenter retrospective study.

Association of 6% hydroxyethyl starch 130/0.4 with acute kidney injury in surgical patients in the postoperative period: a multicenter retrospective study. - Association of 6% hydroxyethyl starch 130/0.4 with acute kidney injury in surgical patients in the postoperative period: a multicenter retrospective study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029075

Enrollment

3000

Registered

2017-09-10

Start date

2017-09-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adult patients who were administered HES 130/0.4 during surgery

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who were administered HES 130/0.4 during surgery

Exclusion criteria

Exclusion criteria: Patients were excluded if they had severe sepsis, pulmonary edema, congestive heart failure, severe chronic kidney disease (CKD) with a decrease in preoperative estimated glomerular filtration rate (pre eGFR) to <44 mL/min/1.73mm2, intracranial bleeding, hypernatremia or hyperchloremia; had undergone cardiac surgery required for cardiopulmonary bypass

Design outcomes

Primary

Measure	Time frame
occurence of acute kidney injury by KDIGO criteria in the postoperative period	—

Countries

Japan

Contacts

Public ContactAtsushi Sawada

Sapporo Medical University School of Medicine Department of Anesthesiology

atusihon7@gmail.com0116112111

Outcome results